-
ASH 2014 Highlights: Thrombosis and Anticoagulation
Stephan Moll, MD writes… The annual American Society of Hematology (ASH) meeting took place in Dec 2014 in San Francisco. A summary of the clinically relevant thrombosis and anticoagulation presentation and abstracts is presented here (Top 10 ASH Highlights). Disclosure: I have been a consultant to Portola, Daiichi, Janssen, and Boehringer-Ingelheim. Last updated: Jan…
-
Two Things Physicians Should Avoid
Stephan Moll, MD writes (Dec 17, 2014)… The American Society of Hematology (ASH) published last week as part of its Choosing Wisely® campaign two things that physicians dealing with DVT, PE and anticoagulants should avoid [ref 1].
-
Highlights of the 2013 ASH Annual Meeting
Stephan Moll, MD writes… The annual meeting of the American Society of Hematology (ASH) took place this month (Dec 6-12th, 2013) in New Orleans. The clinically relevant highlights about thrombosis and anticoagulation are summarized below.
-
Three Things We Shouldn’t Do
Stephan Moll, MD writes… The American Society of Hematology (ASH) has identified 3 things that physicians dealing with DVT, PE and anticoagulation should avoid – published today [ref 1].
-
ASH 2011: Highlights in Thrombosis and Anticoagulation
The annual meeting of the American Society of Hematology (ASH) took place in San Diego from Dec 10-13, 2011. Abstracts on thrombosis and anticoagulation that I found interesting and clinically relevant are summarized and put into a clinical perspective in this summary document. Only one abstract was, in my assessment, clinical-practice-changing – abstract #543: “Aspirin after…
A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center
Clot Connect 